Browse result page of THPdb

The total number entries retrieved from this search are 116

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1441	ThPPIDTh1077	NameUrofollitropin	Peptide SequenceAlpha chain:APDVQDCP Full view	Length203	Functional ClassificationIb	DiseaseHormonal	BrandFertinex	CompanyN.A.	Physical AppearanceSterile, lyophilized form contains an acidic, water soluble glycoprotein biologically standardized for FSH gonadotropin activity	Route of AdministartionSubcutaneous injection.	CategoryFertility Agents	TargetGlutamate carboxypeptidase 2
ID1442	ThPPIDTh1078	NameEfalizumab	Peptide SequenceLight Chain:DIQMTQSP Full view	Length229	Functional ClassificationIIa	DiseaseImmunological	BrandRAPTIVA	CompanyGenentech, Inc.	Physical AppearanceSterile, white to off-white, lyophilized powder in single-use glass vials	Route of AdministartionSubcutaneous injection.ÂÂÂ	CategoryImmunosuppressive Agents	TargetIduronic acid
ID1456	ThPPIDTh1086	NameInterferon Alfa-2B, Recombinant	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandINTRON® A	CompanyMerck	Physical AppearancePowder or solution	Route of AdministartionIntramuscular, Subcutaneous, Intralesional, or Intravenous injection	CategoryImmunosuppressive Agents	TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin
ID1462	ThPPIDTh1088	NameEnfuvirtide	Peptide SequenceYTSLIHSLIEESQNQQEKNE Full view	Length36	Functional ClassificationIIa	DiseaseInfectious	Brand`FUZEON	CompanyTrimeris, Roche	Physical AppearanceWhite to off-white, sterile, lyophilized powder.	Route of AdministartionSubcutaneous injection	CategoryHIV Fusion Inhibitors	TargetOxytocin receptor,Oxytocin-neurophysin 1, Envelope glycoprotein
ID1482	ThPPIDTh1100	NamePramlintide	Peptide SequenceKCNTATCATQRLANFLVHSS Full view	Length37	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandSymlin	CompanyAmylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)	Physical AppearanceClear, isotonic, sterile solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetCalcitonin receptor,Receptor activity-modifying protein 1,Receptor activity-modifying protein 2,Receptor activity-modifying protein 3
ID1495	ThPPIDTh1102	NameAbatacept	Peptide SequenceMHVAQPAVVLASSRGIASFV Full view	Length357	Functional ClassificationIIa	DiseaseImmunological	BrandORENCIA	CompanyBristol-Myers Squibb	Physical AppearanceLyophilized powder, supplied as a sterile, white, preservative-free, lyophilized powder for intravenous administration	Route of AdministartionIntravenous infusion and Subcutaneous injection	CategoryAntirheumatic Agents and Immunosuppressive Agents	TargetT-lymphocyte activation antigen CD80,T-lymphocyte activation antigen CD86
ID1502	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog	CompanyNovo Nordisk	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionSubcutaneous injection, Intravenous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1503	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog Mix 50/50	CompanyNovo Nordisk	Physical AppearanceUniform, white, sterile suspension that contains insulin aspart	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1504	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog Mix 70/30	CompanyNovo Nordisk	Physical AppearanceUniform, white, sterile suspension that contains insulin aspart 100 Units/mL.	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1511	ThPPIDTh1106	NameInsulin Detemir	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandLEVEMIR	CompanyNovo Nordisk	Physical AppearanceClear, colorless, aqueous, neutral sterile solution	Route of AdministartionSubcutaneous injection	CategoryAntidiabetic Agents	TargetInsulin receptor
ID1531	ThPPIDTh1110	NameThymalfasin	Peptide SequenceSDAAVDTSSEITTKDLKEKK Full view	Length28	Functional ClassificationIb	DiseaseInfectious/Immunological	BrandZadaxin	CompanySciClone Pharmaceuticals (SCLN)	Physical AppearanceN.A.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetN.A.
ID1533	ThPPIDTh1112	NameNatural Alpha Interferon Or Multiferon	Peptide SequenceInteferon alpha-1: Full view	Length997	Functional ClassificationIIa	DiseaseCancer/Infectious	BrandIntron/ Roferon-A	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionSubcutaneous injection, Intravenous injection, Intramuscular injection	CategoryN.A.	TargetN.A.
ID1534	ThPPIDTh1113	NameGlatiramer Acetate	Peptide SequenceEAYKAAEKAYAAKEAAKEAA Full view	Length52	Functional ClassificationIIa	DiseaseNeurological Disorder	BrandCopaxone	CompanyTeva Pharmaceutical Industries	Physical AppearanceClear, colorless to slightly yellow, sterile, nonpyrogenic solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetN.A.
ID1535	ThPPIDTh1114	NamePreotact	Peptide SequenceParathyroid hormone: Full view	Length84	Functional ClassificationIb	DiseaseOsteological	BrandPreotactÂÂÂ	CompanyNycomed	Physical AppearanceN.A.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetParathyroid hormone/parathyroid hormone-related peptide receptor,Parathyroid hormone 2 receptor
ID1537	ThPPIDTh1116	NameCanakinumab	Peptide SequenceH-GAMMA-1 (VH(1-118) Full view	Length842	Functional ClassificationIIIb	DiseaseImmunological	BrandILARISÂÂÂ	CompanyNovartis Pharmaceuticals	Physical AppearanceWhite, preservative-free, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryAnti-Inflammatory Agents and Monoclonal antibodies	TargetInterleukin-1 beta
ID1550	ThPPIDTh1119	NameTocilizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandACTEMRA	CompanyGenentech	Physical AppearanceSterile, preservative-free solution, colorless to pale yellow liquid, with a pH of about 6.5	Route of AdministartionIntravenous infusion, Subcutaneous injection	CategoryN.A.	TargetInterleukin-6 receptor subunit alpha
ID1556	ThPPIDTh1120	NameTeriparatide	Peptide SequenceParathyroid hormone Full view	Length34	Functional ClassificationIb	DiseaseOsteological	BrandForteo	CompanyEli Lilly and Company	Physical AppearanceSterile, colorless, clear, isotonic solution	Route of AdministartionSubcutaneous injection	CategoryBone Density Conservation Agents	TargetParathyroid hormone/parathyroid hormone-related peptide receptor
ID1562	ThPPIDTh1122	NameRilonacept	Peptide Sequencerilonacept|Homo sapi Full view	Length880	Functional ClassificationIIa	DiseaseImmunological	BrandArcalyst	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, white to off-white, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterleukin-1 beta,Interleukin-1 alpha,Interleukin-1 receptor antagonist protein
ID1576	ThPPIDTh1124	NameLiraglutide	Peptide SequenceHAEGTFTSDVSSYLEGQAAK Full view	Length33	Functional ClassificationIb	DiseaseHormonal	BrandSaxenda	CompanyNovo Nordisk	Physical AppearanceClear, colorless solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGlucagon-like peptide 1 receptor
ID1577	ThPPIDTh1124	NameLiraglutide	Peptide SequenceHAEGTFTSDVSSYLEGQAAK Full view	Length33	Functional ClassificationIb	DiseaseHormonal	BrandVictoza	CompanyNovo Nordisk	Physical AppearanceClear, colorless solution.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGlucagon-like peptide 1 receptor
ID1583	ThPPIDTh1125	NameGolimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseImmunological	BrandSimponi Injection	CompanyN.A.	Physical AppearanceClear to slightly opalescent, colorless to light yellow solution	Route of AdministartionSubcutaneous injection	CategoryAntipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	TargetTumor necrosis factor
ID1601	ThPPIDTh1127	NameBuserelin	Peptide SequencepGlu-His-Trp-Ser-Tyr Full view	Length9	Functional ClassificationIIIc	DiseaseCancer/Hormonal	BrandSuprecur (injection)	CompanySanofi-Aventis	Physical Appearance1mg/ml Injection	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor
ID1603	ThPPIDTh1129	NameTesamorelin	Peptide SequenceYADAIFTNSYRKVLGQLSAR Full view	Length44	Functional ClassificationIb	DiseaseHormonal	BrandEgrifta	CompanyTheratechnologies	Physical AppearanceSterile, white to off-white, preservative-free lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGrowth hormone-releasing hormone receptor
ID1624	ThPPIDTh1137	NameTeduglutide	Peptide SequenceHGDGSFSDEMNTILDNLAAR Full view	Length33	Functional ClassificationIa	DiseaseMalabsorption disorder	BrandGattex	CompanyNPS Pharmaceuticals, Inc	Physical AppearanceClear, colorless to light-straw–colored liquid.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGlucagon-like peptide 2 receptor
ID1628	ThPPIDTh1139	NameCertolizumab Pegol	Peptide SequenceLight chain: DIQMTQS Full view	Length443	Functional ClassificationIIb	DiseaseImmunologcal	BrandCimzia	CompanyUCB	Physical AppearanceSterile, white, lyophilized powder for solution or as a sterile, solution in a single-use prefilled 1 mL glass syringe	Route of AdministartionSubcutaneous injection	CategoryTNF inhibitor	TargetTumor necrosis factor
ID1634	ThPPIDTh1140	NameInsulin, Isophane Or Nph Insulin (Neutral Protamine Hagedorn)	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovolin N	CompanyNovo Nordisk	Physical AppearanceNovolin N InnoLet (nph, human insulin isophane suspension 3 ml disposable prefilled syringe)	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1638	ThPPIDTh1144	NameFollitropin Alpha	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIb	DiseaseAdjunct therapy/ Hormonal	BrandGonal-F	CompanySerono Laboratories	Physical AppearanceSterile, lyophilized powder.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetN.A.
ID1639	ThPPIDTh1144	NameFollitropin Alpha	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIb	DiseaseAdjunct therapy/ Hormonal	BrandGonal-f RFF	CompanyEMD SERONO	Physical AppearanceSterile, lyophilized powde	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetN.A.
ID1640	ThPPIDTh1145	NameRomiplostim	Peptide SequenceThrombopoietin recep Full view	Length269	Functional ClassificationIb	DiseaseImmunologcal	BrandNplate	CompanyAmgen	Physical AppearanceSterile, preservative-free, lyophilized, solid white powder	Route of AdministartionSubcutaneous injection	CategoryColony-Stimulating Factors and Thrombopoietic Agents	TargetN.A.
ID1654	ThPPIDTh1150	NameSecukinumab	Peptide SequenceSecukinumab Heavy Ch Full view	Length672	Functional ClassificationIIa	DiseaseImmunological	BrandCosentyx	CompanyNovartis Pharmaceuticals Corporation	Physical AppearanceSterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution.	Route of AdministartionSubcutaneous injection	CategoryInhibitor	TargetIL-17A cytokine
ID1655	ThPPIDTh1151	NameSomatotropin Recombinant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length192	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandNutropinAQ	CompanyGenentech Inc.	Physical AppearanceSterile, white lyophilized powder intended for subcutaneous administration after reconstitution with Bacteriostatic Water	Route of AdministartionSubcutaneous administration	CategoryHormone Replacement Agents	TargetGrowth hormone receptor, Prolactin receptor
ID1656	ThPPIDTh1151	NameSomatotropin Recombinant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length192	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandBioTropin	CompanyBio-Technology General (Israel) Ltd.	Physical AppearanceSterile, white, lyophilized powder	Route of AdministartionSubcutaneous administration	CategoryHormone Replacement Agents	TargetGrowth hormone receptor, Prolactin receptor
ID1657	ThPPIDTh1151	NameSomatotropin Recombinant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length192	Functional ClassificationIb	DiseaseHormonal/Metabolic	BrandProtropin	CompanyGenentech Inc.	Physical AppearanceSterile, white, lyophilized powder	Route of AdministartionIntramuscular or subcutaneous administration	CategoryHormone Replacement Agents	TargetGrowth hormone receptor, Prolactin receptor
ID1666	ThPPIDTh1157	NameSermorelin	Peptide SequenceYADAIFTNSYRKVLGQLSAR Full view	Length30	Functional ClassificationIa	DiseaseHormonal	BrandSermorelin acetate	CompanyEmd serono inc	Physical AppearanceSterile, non-pyrogenic, lyophilized powder	Route of AdministartionSubcutaneous Injection	CategoryHormone Replacement Agents	TargetGrowth hormone-releasing hormone receptor
ID1674	ThPPIDTh1161	NameAlbiglutide	Peptide SequenceHGEGTFTSDVSSYLEGQAAK Full view	Length645	Functional ClassificationIb	DiseaseHormonal disorders	BrandEperzan	CompanyGlaxosmithkline Inc	Physical AppearancePowder for Solution	Route of AdministartionSubcutaneous	CategoryDrugs used in diabetes; alimentary tract and metabolism; blood glucose lowering drugs, excl. insulins.	TargetGlucagon-like peptide 1 receptor
ID1676	ThPPIDTh1161	NameAlbiglutide	Peptide SequenceHGEGTFTSDVSSYLEGQAAK Full view	Length645	Functional ClassificationIb	DiseaseHormonal disorders	BrandTanzeum	CompanyGlaxo Smith Kline Llc	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionSubcutaneous	CategoryDrugs used in diabetes; alimentary tract and metabolism; blood glucose lowering drugs, excl. insulins.	TargetGlucagon-like peptide 1 receptor
ID1678	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis U.S. Llc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 9
ID1679	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 10
ID1680	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 11
ID1681	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis U.S. Llc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 14
ID1682	ThPPIDTh1163	NameAncestim	Peptide SequenceNA Full view	Length0	Functional ClassificationIb	DiseaseCancer	BrandStemgen	CompanyBiovitrum Ab (publ)	Physical AppearanceNA	Route of AdministartionSubcutaneous	CategoryNA	TargetNA
ID1694	ThPPIDTh1166	NameAsfotase Alfa	Peptide SequenceLVPEKEKDPKYWRDQAQETL Full view	Length726	Functional ClassificationIa	DiseaseGenetic Disorders	BrandStrensiq	CompanyAlexion Pharma Ghbh	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryEnzymes Alimentary Tract and Metabolism	TargetSphingosine 1-phosphate receptor 1; Pyrophosphate
ID1695	ThPPIDTh1166	NameAsfotase Alfa	Peptide SequenceLVPEKEKDPKYWRDQAQETL Full view	Length726	Functional ClassificationIa	DiseaseGenetic Disorders	BrandStrensiq	CompanyAlexion Pharmaceuticals Inc.	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryEnzymes Alimentary Tract and Metabolism	TargetSphingosine 1-phosphate receptor 1; Pyrophosphate
ID1726	ThPPIDTh1175	NameDesirudin	Peptide SequenceNA Full view	Length0	Functional ClassificationIb	DiseaseHematological Disorders	BrandIprivask	CompanyValeant Pharmaceuticals North America LLC	Physical AppearanceNA	Route of AdministartionSubcutaneous	CategoryNA	TargetNA
ID1729	ThPPIDTh1176	NameDulaglutide	Peptide SequenceHGEGTFTSDVSSYLEEQAAK Full view	Length275	Functional ClassificationIb	DiseaseMetabolic Disorders	BrandTrulicity	CompanyEli Lilly and Company	Physical AppearanceSolution, Injection	Route of AdministartionSubcutaneous	CategoryHypoglycemic Agents; Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins	TargetGlucagon-like peptide 1 receptor
ID1730	ThPPIDTh1176	NameDulaglutide	Peptide SequenceHGEGTFTSDVSSYLEEQAAK Full view	Length275	Functional ClassificationIb	DiseaseMetabolic Disorders	BrandTrulicity	CompanyEli Lilly Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryHypoglycemic Agents; Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins	TargetGlucagon-like peptide 1 receptor
ID1741	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandNA	CompanyNA	Physical AppearanceInjection, Solution; Injection	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 9
ID1742	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Inc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 10
ID1743	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 11
ID1744	ThPPIDTh1179	NameEvolocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Cardiac	BrandRepatha	CompanyAmgen Inc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryLipid Modifying Agents, Plain; Cardiovascular System	TargetProprotein convertase subtilisin/kexin type 12